Delving into the Latest Updates on Rose Pharma A/S with Synapse

Overview

This trial will study the effects of an investigational (not FDA approved) medication, ROSE-010, on the movement of food through the stomach, small intestine and colon in females with constipation predominant irritable bowel syndrome (C-IBS).
The study hypothesis is that ROSE-010 will delay gastric emptying of solids and enhances gastric accommodation without retarding colonic transit in female patients with C-IBS.

Start Date01 Jan 2010

Sponsor / Collaborator

Mayo Clinic

[+2]

100 Clinical Results associated with Rose Pharma A/S

Login to view more data

0 Patents (Medical) associated with Rose Pharma A/S

Login to view more data

100 Deals associated with Rose Pharma A/S

Login to view more data

100 Translational Medicine associated with Rose Pharma A/S

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

2

Login to view more data